
Journal of Medicinal Chemistry p. 357 - 366 (1987)
Update date:2022-08-04
Topics:
Lunt, Edward
Newton, Christopher G.
Smith, Christopher
Stevens, Graham P.
Stevens, Malcolm F. G.
et al.
The systematic variation of the potent antitumor agent mitozolomide (1) is extended to cover alteration of substituents at position 6 and 8 and to change the imidazo<5,1-d>-1,2,3,5-tetrazinone (6) skeleton to the isomeric pyrazolo<5,1-d>-1,2,3,5-tetrazino
View MoreTianjin Bright Future Technology Co., Ltd
Contact:0086-22-58016666
Address:NO.136 DongTeng Lake Street Tianjin Economic and Technology Development Area,Tainjin,China
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
ShanDong XinDa Chemical CO.,LTD(expird)
Contact:086-0311-87580543
Address:No.168, High Technology Development Zone Jinan Shandong China
Ji'an Hairui Natural Plant Co. Ltd.
Contact:0796-8105528
Address:Meilin industry park, Qingyuan district Ji'an City, Jiangxi Province
Contact:+86-532-80762375
Address:No. 6, Hongkong Middle Road, Qingdao, China
Doi:10.1021/acs.orglett.7b03509
(2018)Doi:10.1021/ja00328a031
(1984)Doi:10.1021/ol061123c
(2006)Doi:10.1016/0040-4039(91)80043-6
(1991)Doi:10.1039/b605498f
(2006)Doi:10.1007/BF00515636
(1984)